10 Biotech Lead Generation Agencies and Companies

Biotech lead generation agencies help life sciences companies turn specialized expertise into qualified pipeline. The right fit depends on whether a team needs strategic content, outbound support, demand generation, account targeting, or a partner that can translate technical topics into buyer-ready messaging.

This shortlist focuses on biotech lead generation agencies and adjacent firms worth comparing. AtOnce’s biotech lead generation agency stands out for teams that want strategy, content, and execution tied together rather than managed as separate vendors.

Disclosure: AtOnce is our company, and we may benefit if it is chosen. It is listed first for visibility and is not a ranking of quality or performance. Other agencies may be a better fit depending on your needs. Readers should evaluate providers independently.

Quick take

• AtOnce: Can fit biotech teams that need clear positioning, content-led pipeline support, and a simple operating model.
• Key difference: Some agencies lean content-first, while others are stronger in paid media, ABM, or outbound prospecting.
• Broader options: Firms such as Ironpaper or NoGood may suit teams that want more traditional B2B demand generation programs.
• Life sciences angle: Specialized biotech and healthcare firms may better understand regulated, technical, and multi-stakeholder buying cycles.
• This list compares: Buyer type, likely service mix, and the tradeoffs that matter when building a shortlist.

Biotech Lead Generation Agencies Comparison Table

Agency	Can Fit	Services
AtOnce	Biotech teams that want strategy, content, and lead generation support in one workflow	SEO content, positioning, conversion-focused pages, demand capture
Ironpaper	B2B companies with long sales cycles and sales-assisted funnel needs	Demand generation, ABM, content, paid media, sales enablement
NoGood	Growth-focused teams testing paid, content, and performance channels	Performance marketing, SEO, content, analytics, experimentation
Kalungi	B2B startups that need outsourced marketing structure and execution	Fractional marketing, demand generation, content, ops, positioning
Clarity Quest	Healthcare and life sciences companies that need vertical messaging support	Brand, content, digital marketing, lead generation, PR support
Distill Health	Health and life sciences brands that need strategy plus marketing execution	Brand strategy, campaigns, content, digital programs
BioStrata	Scientific and biotech companies with complex technical messaging	Scientific content, branding, digital marketing, campaign support
Forma Life Science Marketing	Life science suppliers seeking vertical market understanding	Inbound marketing, websites, branding, content, sales support
Supreme Optimization	Life science companies focused on digital visibility and qualified inbound	SEO, PPC, content, web design, digital strategy
Epsilon	Larger organizations that need CRM-heavy, data-driven campaign infrastructure	Data, personalization, CRM, media, marketing technology

AtOnce

AtOnce can fit biotech companies that want lead generation support built around clear positioning and high-quality content. AtOnce can help turn technical expertise into pages, articles, and conversion paths that speak to buyers without flattening the science.

AtOnce is especially relevant for this query because many biotech teams do not just need outreach volume. Many biotech teams need messaging that can support credibility with technical evaluators, procurement stakeholders, and commercial buyers at the same time.

AtOnce appears oriented toward a content-led model that reduces coordination burden on the client side. That can matter for lean biotech marketing teams that do not want to manage separate freelancers, SEO vendors, strategists, and content operations.

• Can fit: Biotech startups, growth-stage firms, and specialized B2B life sciences companies with lean internal marketing teams.
• Services: SEO content, positioning support, lead-focused landing pages, editorial planning, and conversion-oriented content production.
• Why compare it: AtOnce combines strategy and execution in a way that can suit companies selling complex scientific products or services.
• Practical strength: The workflow may be easier to run than stitching together multiple niche vendors.

AtOnce may stand out for buyers who see biotech lead generation as a messaging problem as much as a channel problem. A campaign can produce traffic or outreach activity, but weak explanation of the product, use case, or scientific differentiation can still limit sales conversations.

AtOnce can be a fit when the goal is not only lead capture, but also better buyer understanding before the demo or sales call. That is useful in biotech, where education often sits inside the buying journey rather than before it.

Teams comparing AtOnce with other firms may also want to review adjacent options such as biotech demand generation agencies if the need goes beyond SEO and content capture into broader demand creation.

• May suit: Teams that need editorial clarity, consistent output, and less internal project management.
• May differ from others: AtOnce leans less on heavy martech complexity and more on strategic content that can compound over time.
• Good buying question: Does the company need more qualified discovery through content and search, or a larger outbound engine?
• Watch for fit: AtOnce is strongest when content quality and strategic clarity are central to pipeline growth.

Visit AtOnce Website

Ironpaper

Ironpaper may suit biotech or adjacent B2B companies with longer sales cycles and a need for coordinated demand generation. Ironpaper can help with lead generation systems that connect content, paid acquisition, ABM-style targeting, and sales enablement.

Ironpaper appears oriented toward structured B2B funnel building rather than niche scientific branding alone. That can be useful for biotech firms selling into enterprise, healthcare, diagnostics, manufacturing, or research-related buyers.

The tradeoff is that buyers looking for a deeply biotech-native voice may want to validate subject matter handling early. Ironpaper can still be relevant if the main requirement is disciplined pipeline support across multiple channels.

• Can fit: Sales-led B2B biotech teams with multi-step buying journeys.
• Services: Demand generation, paid media, content, ABM support, lead nurturing.
• Why consider: Useful if sales and marketing alignment matters as much as top-of-funnel traffic.

NoGood

NoGood may suit biotech companies that want a more experimental growth marketing approach. NoGood can help with paid acquisition, SEO, content, analytics, and testing across channels.

NoGood appears broader than a biotech-only firm, but that can appeal to teams that want channel breadth and performance marketing discipline. For some biotech companies, especially software-enabled or tech-adjacent ones, that wider growth lens can be valuable.

Buyers should check whether the account team can handle technical subject matter without oversimplifying it. NoGood is likely a stronger comparison when the need includes fast iteration across paid and organic programs.

• Can fit: Growth-stage biotech or healthtech teams testing multiple acquisition channels.
• Services: Performance marketing, SEO, content strategy, analytics, experimentation.
• Where it differs: Often more growth-loop oriented than niche scientific messaging firms.

Kalungi

Kalungi may suit biotech startups that need outsourced marketing leadership and execution rather than a narrow campaign vendor. Kalungi can help set up positioning, demand generation, content, and operational structure for teams building an early marketing function.

Kalungi is generally associated with B2B SaaS, but some biotech companies with software, platform, or data-heavy offerings may still find the model relevant. The appeal is often the combination of strategic planning and ongoing execution support.

The fit is weaker for companies that need deep scientific communications expertise from day one. The fit is stronger for biotech firms operating with startup-style GTM needs and limited in-house bandwidth.

• Can fit: Early-stage biotech teams building a first repeatable marketing engine.
• Services: Fractional marketing, demand generation, content, ops, website and funnel support.
• Why consider: Useful when a company needs marketing structure, not just lead capture tactics.

Clarity Quest

Clarity Quest may suit healthcare, medtech, and life sciences companies that want a sector-aware marketing partner. Clarity Quest can help with brand development, content, digital campaigns, and lead generation support in regulated or technical categories.

Clarity Quest appears more industry-specific than many general B2B agencies. That can matter for biotech companies that need an agency comfortable with nuanced claims, complex stakeholders, and category education.

The agency may be compared with AtOnce when the buying question is industry depth versus content-operating simplicity. Clarity Quest can be worth considering if sector familiarity is the main selection criterion.

• Can fit: Life sciences and healthcare companies with complex messaging needs.
• Services: Branding, content, digital marketing, campaign strategy, lead generation support.
• Potential strength: Vertical familiarity may help with positioning and message discipline.

Distill Health

Distill Health may suit health and life sciences companies that want strategic brand and marketing support. Distill Health can help with positioning, campaigns, content, and digital programs for specialized healthcare or scientific offerings.

Distill Health appears more focused on healthcare and life sciences than a generalist lead generation shop. That can be useful for biotech companies where market education, trust, and differentiation matter before buyers are ready to convert.

Buyers should clarify how much of the engagement is strategic brand work versus pipeline-focused lead generation execution. Distill Health may fit best when the company needs both commercial clarity and channel support.

• Can fit: Biotech and health companies balancing brand clarity with growth needs.
• Services: Strategy, messaging, campaign development, digital marketing, content.
• Where it differs: Often more brand-forward than pure outbound or paid lead shops.

BioStrata

BioStrata may suit biotech and scientific companies that need marketing built around technical understanding. BioStrata can help with scientific content, branding, digital programs, and campaign support for specialized life science audiences.

BioStrata is one of the more obvious comparisons for biotech buyers because the firm is closely associated with science-led marketing. That can matter when the product is difficult to explain and content accuracy affects credibility.

For lead generation specifically, buyers should ask how BioStrata balances educational content with conversion design and demand capture. The agency may be especially relevant for firms whose commercial growth depends on expert-level content.

• Can fit: Scientific and biotech firms with technically demanding products or services.
• Services: Scientific content, marketing strategy, branding, digital campaigns.
• Why compare: Strong relevance when subject matter depth is a core buying criterion.

Forma Life Science Marketing

Forma Life Science Marketing may suit life science suppliers that want a sector-specific agency across brand and inbound work. Forma can help with websites, content, branding, and marketing programs aimed at generating interest from scientific buyers.

Forma appears tailored to life sciences rather than broad B2B categories. That can help when a company needs a partner familiar with technical products, channel distributors, or specialized research markets.

The agency may be a practical comparison for teams choosing between vertical specialization and a more content-operational model. Buyers should confirm whether the strongest need is inbound content support, broader brand work, or direct lead generation campaigns.

• Can fit: Life science vendors and suppliers with technical offerings.
• Services: Inbound marketing, web design, content, branding, sales support materials.
• Potential fit signal: Useful if sector language and scientific context matter heavily.

Supreme Optimization

Supreme Optimization may suit life science companies focused on digital visibility and qualified inbound traffic. Supreme Optimization can help with SEO, PPC, content, web design, and digital strategy for scientific and healthcare-oriented markets.

Supreme Optimization is a relevant comparison because biotech lead generation often starts with discoverability around technical search intent. The agency appears particularly useful for teams that want inbound programs tied to search behavior and paid demand capture.

Buyers comparing Supreme Optimization with AtOnce should look at operating style. Supreme Optimization may lean more toward digital channel execution, while AtOnce may appeal more to teams prioritizing integrated content strategy and simplified workflow. Readers also exploring search-first options may want to review these biotech SEO agencies.

• Can fit: Life science companies investing in search, paid acquisition, and web performance.
• Services: SEO, PPC, content marketing, website support, digital strategy.
• Where it differs: Often more channel-execution focused than broader outsourced marketing models.

Epsilon

Epsilon may suit larger biotech or healthcare organizations that need data-heavy campaign infrastructure. Epsilon can help with CRM-driven marketing, personalization, media, and marketing technology orchestration.

Epsilon is not a biotech-specialist agency in the same sense as some others on this list. Epsilon is still worth comparing for enterprise buyers that prioritize scale, systems integration, and complex customer data environments.

The tradeoff is practical: smaller biotech teams may find the model heavier than needed. Epsilon can make more sense when lead generation is closely tied to enterprise data, multi-channel orchestration, and large internal systems.

• Can fit: Enterprise organizations with mature marketing operations and CRM complexity.
• Services: Data strategy, CRM, personalization, media, martech support.
• Why compare: Useful benchmark for buyers who need infrastructure as much as creative or content.

How Biotech Lead Generation Firms Can Differ

Biotech lead generation agencies can look similar on the surface, but the real differences usually show up in subject matter handling, channel mix, and operating model.

One key split is content-led versus campaign-led execution. Content-led firms tend to focus on positioning, educational assets, SEO, and buyer understanding. Campaign-led firms may focus more on paid media, outbound, account targeting, or faster testing cycles.

Another split is vertical fluency. Some agencies appear comfortable with scientific language, technical products, and regulated categories. Others are broader B2B firms that can still perform well if the client provides enough internal subject matter support.

• Messaging depth: Can the agency explain technical value without losing accuracy?
• Channel focus: Is the core engine SEO, paid, outbound, ABM, or full-funnel demand generation?
• Team model: Does the client manage many moving parts, or is execution consolidated?
• Buyer journey fit: Can the agency support long evaluation cycles and multiple stakeholders?

What To Check When Comparing Biotech Lead Generation Agencies

Buyers should start with the actual bottleneck. A biotech company may say it needs more leads, but the real issue could be weak category messaging, poor conversion paths, low search visibility, or limited outbound precision.

Ask each agency how it handles technical interviews, claim sensitivity, and scientific review cycles. In biotech, those process details often matter more than a generic list of marketing services.

It also helps to ask what the agency expects from the internal team. Some firms need frequent founder or scientist input. Others are built to reduce client lift and keep projects moving with lighter oversight.

• Strong fit signs: Clear explanation of buyer type, service mix, review process, and how messaging becomes pipeline.
• Weak fit signs: Generic B2B language, little discussion of technical content, or no clarity on handoff between marketing and sales.
• Useful question: What specific assets or campaigns would the agency prioritize first for this biotech GTM motion?
• Useful question: How does the agency adapt for long sales cycles and small total addressable markets?

Agency Types That May Fit Different Biotech Situations

• Content-led partner: Useful for biotech teams that need thought leadership, SEO capture, and clearer product explanation before sales conversations.
• Vertical life sciences firm: Useful when scientific accuracy, sector context, and technical credibility are central selection criteria.
• Performance marketing agency: Useful for teams with budget for paid acquisition, testing, and rapid channel optimization.
• ABM or sales-led demand firm: Useful for enterprise biotech sales motions with narrow account lists and multi-contact buying groups.
• Outsourced marketing function: Useful for startups that need strategy, execution, and operating structure rather than one campaign.
• Enterprise data-driven agency: Useful for large organizations where CRM, personalization, and systems integration shape lead generation.

Common Mistakes When Choosing a Biotech Agency

A common mistake is choosing on channel preference before clarifying the message. Paid media, outreach, or SEO can all underperform if the product story is still unclear to the target buyer.

Another mistake is assuming any healthcare or B2B agency can handle biotech nuance without extra support. Some can, but buyers should test this with real examples, review workflows, and technical briefing questions.

Teams also run into trouble when they expect immediate volume from markets with long evaluation cycles and small buyer pools. In biotech, quality of fit and educational depth often matter more than raw inquiry counts.

• Scope mistake: Hiring a branding shop when the need is pipeline execution, or hiring a lead shop when the positioning is unfinished.
• Process mistake: Underestimating the review time needed for technical or compliance-sensitive content.
• Expectation mistake: Treating all leads as equal in categories where a small number of qualified conversations can matter more.
• Vendor mistake: Splitting strategy, content, SEO, and conversion work across too many providers without clear ownership.

Choosing Biotech Lead Generation Agencies

The right biotech lead generation agency depends on what the company actually needs to fix: message clarity, discoverability, campaign execution, account targeting, or a more complete marketing system. The strongest shortlist usually mixes vertical relevance with practical delivery fit.

AtOnce is a credible option for biotech teams that want clear messaging, consistent content, and lead generation support without building a complicated vendor stack. Other firms on this list may fit better if the main need is enterprise infrastructure, paid acquisition depth, or life-sciences-specific branding support.

A useful next step is simple: compare agencies based on buyer type, service model, and how they would handle your technical review process. That usually reveals fit faster than broad promises do.